OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications
Michael J. Thorpy, Richard Bogan
Sleep Medicine (2019) Vol. 68, pp. 97-109
Closed Access | Times Cited: 64

Showing 26-50 of 64 citing articles:

Narcolepsy Treatment: Voices of Adolescents
Lena Xiao, Anna Chen, Arpita Parmar, et al.
Behavioral Sleep Medicine (2021) Vol. 20, Iss. 2, pp. 260-268
Closed Access | Times Cited: 7

How treatable is narcolepsy with current pharmacotherapy and what does the future hold?
Gaia Pellitteri, Stefano de Biase, Mariarosaria Valente, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 12, pp. 1517-1520
Closed Access | Times Cited: 7

Narcolepsy
Diana C. Anderson
JAAPA (2021) Vol. 34, Iss. 6, pp. 20-25
Open Access | Times Cited: 7

How hypocretin agonists may improve the quality of wake in narcolepsy
J.L. Justinussen, Christine Egebjerg, Birgitte Rahbek Kornum
Trends in Molecular Medicine (2022) Vol. 29, Iss. 1, pp. 61-69
Closed Access | Times Cited: 5

Drugs for patients with epilepsy and excessive daytime sleepiness
Gaetano Zaccara, Emanuele Bartolini, Luciana Tramacere, et al.
Epilepsy & Behavior (2021) Vol. 124, pp. 108311-108311
Closed Access | Times Cited: 7

Clinical Characteristics of Cataplectic Attacks in Type 1 Narcolepsy
Arpita Parmar, Brian J. Murray, Indra Narang
Current Neurology and Neuroscience Reports (2020) Vol. 20, Iss. 9
Closed Access | Times Cited: 6

Emerging therapeutic targets for narcolepsy
Marieke Vringer, Birgitte Rahbek Kornum
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 7, pp. 559-572
Closed Access | Times Cited: 6

Clinical Evaluation and Management of Narcolepsy in Children and Adolescents
Thomas J. Dye
Seminars in Pediatric Neurology (2023) Vol. 48, pp. 101089-101089
Closed Access | Times Cited: 2

A Randomized, Double‐Blind, Placebo‐ and Positive‐Controlled, 4‐Period Crossover Study of the Effects of Solriamfetol on QTcF Intervals in Healthy Participants
Katie Zomorodi, Dan Chen, Lawrence Lee, et al.
Clinical Pharmacology in Drug Development (2020) Vol. 10, Iss. 4, pp. 404-413
Open Access | Times Cited: 5

Sleep Disorders in Adolescence
Omna Chawla, Ravi Gupta
Sleep and Vigilance (2020) Vol. 4, Iss. 2, pp. 137-144
Closed Access | Times Cited: 5

Solriamfetol for the Management of Excessive Daytime Sleepiness
Megan C Cuomo, Amy Sheehan, Joe K Jordan
Journal of Pharmacy Practice (2021) Vol. 35, Iss. 6, pp. 963-970
Closed Access | Times Cited: 5

Narcolepsy in Children: Sleep disorders in children, A rapidly evolving field seeking consensus
Thomas J. Dye, Narong Simakajornboon
Pediatric Pulmonology (2021) Vol. 57, Iss. 8, pp. 1952-1962
Closed Access | Times Cited: 5

Analgesic and anti-inflammatory effects of modafinil in a mouse model of neuropathic pain: A role for nitrergic and serotonergic pathways
Hossein Ghorbanzadeh, Parastoo Mohebkhodaei, Mehran Nematizadeh, et al.
Neurological Research (2021) Vol. 44, Iss. 5, pp. 390-402
Closed Access | Times Cited: 5

REM Sleep in Narcolepsy
Michael J. Thorpy, Jerome M. Siegel, Yves Dauvilliers
Sleep Medicine Reviews (2024) Vol. 77, pp. 101976-101976
Open Access

Hypnosis: An aid in working with patients with narcolepsy
Lewis J. Kass
American Journal of Clinical Hypnosis (2024) Vol. 66, Iss. 4, pp. 343-349
Closed Access

LC–MS/MS method for the quantification of SUVN-G3031, a novel H3 receptor inverse agonist for narcolepsy treatment
Ramakrishna Nirogi, Devender Reddy Ajjala, Naga Surya Prakash Padala, et al.
Bioanalysis (2020) Vol. 12, Iss. 8, pp. 533-544
Closed Access | Times Cited: 3

Narcolepsy, How do We Manage it?
Hyunwoo Kim, Jae Wook Cho
Journal of Sleep Medicine (2020) Vol. 17, Iss. 1, pp. 1-10
Open Access | Times Cited: 3

Psychofarmaca en de behandeling van slaapstoornissen
Maaike van Veen, Jeanine Kamphuis, Rixt Riemersma-van der Lek
Bohn Stafleu van Loghum eBooks (2020), pp. 403-466
Closed Access | Times Cited: 3

Pharmacological options for narcolepsy: are they the way forward?
Vivien C. Abad
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 9, pp. 819-834
Closed Access | Times Cited: 1

Stimulating meditation: a pre-registered randomised controlled experiment combining a single dose of the cognitive enhancer, modafinil, with brief mindfulness training
Emily M Thomas, Tom P. Freeman, Patrick Poplutz, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 6, pp. 621-630
Open Access | Times Cited: 3

The Development of Sleep/Wake Disruption and Cataplexy as Hypocretin/Orexin Neurons Degenerate in Male vs. Female Orexin/tTA; TetO-DTA Mice
Yu Sun, Ryan K. Tisdale, Sunmee Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3

Methamphetamine and MDMA Neurotoxicity: Biochemical and Molecular Mechanisms
Verónica Bisagno, Jean Lud Cadet
Springer eBooks (2022), pp. 563-585
Closed Access | Times Cited: 2

Pitolisant for Treating Narcolepsy Comorbid With Schizophrenia
Clément Dondé, Mircea Polosan, Rita Guzun
Journal of Clinical Psychopharmacology (2020) Vol. 40, Iss. 5, pp. 504-506
Closed Access | Times Cited: 2

Neuroenhancement: State of the Art and Future Perspectives.
Donatella Marazziti, Maria Teresa Avella, Tea Ivaldi, et al.
PubMed (2021) Vol. 18, Iss. 3, pp. 137-169
Closed Access | Times Cited: 2

Scroll to top